| Braun, M.; Gluz, O.; Nitz, U.; Christgen, M.; Kuemmel, S.; Schumacher, C.; Potenberg, J.; Kraemer, S.; Kleine-Tebbe, A.; Augustin, D.; Aktas, B.; Forstbauer, H.; Tio, J.; Liedtke, C.; Kates, R. E.; Wuerstlein, R.; Kreipe, H.-H.; Harbecks, N. (2016): Final analysis of WSG-ADAPT HER2+/HR+ phase-II-trial - efficacy, safety and predictive markers for 12-weeks of neoadjuvant T-DM1 with or without endocrine therapy versus Trastuzumab plus endocrine therapy in HER2-positive hormone-receptor-positive early breast cancer. In: Oncology Research and Treatment, Vol. 39: p. 2 |
Full text not available from 'Open Access LMU'.
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 2296-5270 |
| Language: | English |
| ID Code: | 45030 |
| Deposited On: | 27. Apr 2018 08:07 |
| Last Modified: | 27. Apr 2018 08:07 |
Repository Staff Only: item control page
